Milton Packer
Cardiovascular Disease · Dallas, TX
CMS Profile ID: 11946311 · NPI: 1083588552
Total Disclosed General Payments
$529,588.27
General-payment records
24
CMS Program Year
2025
Most of this (about 99%) was consulting fees.
Payments by Type
| Payment Type | Amount |
|---|---|
| Consulting Fee | $522,745.25 |
| Travel and Lodging | $6,557.76 |
| Food and Beverage | $285.26 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| Eli Lilly and Company | $489,917.06 |
| Novo Nordisk Inc | $23,518.85 |
| Novo Nordisk AS | $10,600.01 |
| Amgen Inc. | $4,524.00 |
| Regeneron Pharmaceuticals, Inc. | $991.25 |
| Medtronic, Inc. | $37.10 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2025 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by exact NPI 1083588552 on the
official CMS Open Payments portal.
Verify this record with CMS
- Confirm the provider's exact NPI: 1083588552.
- Select program year 2025 and general payments in the CMS portal.
- Check individual payment records and their nature-of-payment categories.